Publication | Closed Access
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.
47
Citations
6
References
2013
Year
A first series of six patients with uterine cancer treated with WT1 mRNA-electroporated DCs is presented herein. Oncological and immunological responses were observed and are supportive for further research.
| Year | Citations | |
|---|---|---|
Page 1
Page 1